等待开盘 03-28 09:30:00 美东时间
+1.660
+3.13%
Legence (NASDAQ:LGN) raises FY2026 sales outlook from $3.500 billion-$3.700 billion to $3.700 billion-$3.900 billion.
03-27 19:34
Companies Reporting Before The Bell • Instil Bio (NASDAQ:TIL) is expected to re...
03-27 19:11
Legence (NASDAQ:LGN) sees Q1 sales of $925.000 million-$950.000 million vs $724.841 million analyst estimate.
03-27 19:04
Legence (NASDAQ:LGN) sees FY2026 sales of $2.650 billion-$2.850 billion vs $2.631 billion analyst estimate.
2025-11-14 20:16